Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound)
Patients interested in access should speak to their GP or consult the NIHR 'Be Part of Research' service to identify eligible clinical trials
20 GeyikS.AltunskE.NeyalA
Studies also prove that GLP medications are considered not just for weight loss maintenance but as part of a broader strategy for long-term metabolic and cardiovascular health benefits
25 June 2025 A Correction to this paper has been published: References Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR, et al